Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma.

Brandes, A

Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma. [electronic resource] - Acta oncologica (Stockholm, Sweden) 2001 - 879-81 p. digital

Publication Type: Case Reports; Journal Article

0284-186X

10.1080/02841860152703544 doi


Adenocarcinoma--immunology
Antineoplastic Agents, Hormonal--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--analysis
CA-19-9 Antigen--blood
Carcinoembryonic Antigen--blood
Disease Progression
Drug Resistance, Neoplasm
Humans
Liver Neoplasms--secondary
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Metastasis
Prostatic Neoplasms--immunology